Obesity trials in Denmark
59 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Aarhus N, Gandrup, Herlev, Holbæk, Hvidovre, Middelfart, Odense C, Vejle
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - No phaseNot yet taking people in DenmarkEffectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents
- Where
- Hobro, Kruså
- Age
- 7 years to 14 years
- People
- 200
- Run by
- University of Aarhus
See details and how to joinNCT07301541 - Phase 3Taking peopleA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Where
- Aarhus N, Herlev, Holbæk, Hvidovre, Slagelse
- Age
- 18 years and over
- People
- 3,900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843498 · EU 2026-526188-39-00 - Phase 3Not yet taking people in DenmarkA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Esbjerg, Herning, Holbæk, Hvidovre, Viborg
- Age
- 18 years and over
- People
- 1,408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - Phase 3Taking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Aarhus, Copenhagen, Gistrup, Odense, Vejle
- Age
- 18 years to 70 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - Phase 3Taking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Aarhus, Copenhagen, Gistrup, Odense, Vejle
- Age
- 18 years to 70 years
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - Phase 3Taking peopleEfficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Where
- Gandrup, Herlev, Vejle
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00 - No phaseTaking peopleHypothalamic GLP-1 Response in Healthy Weight and Obesity
- Where
- Copenhagen
- Age
- 18 years to 75 years
- People
- 60
- Run by
- University of Copenhagen
See details and how to joinNCT07854886 - Phase 2Not yet taking people in DenmarkSemaglutide for Weight Management During Hormone Therapy for Early Breast Cancer
- Where
- Aarhus N
- Age
- 18 years and over
- People
- 32
- Run by
- Aarhus University Hospital
See details and how to joinNCT07909889 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Aarhus N, Esbjerg, Frederiksberg, Herlev, Herning, Hvidovre, Roskilde
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 4Taking peopleFutureShape Family
- Where
- Copenhagen
- Age
- 5 years and over
- People
- 400
- Run by
- Signe Torekov
See details and how to joinNCT07872904 - No phaseEnrolling by invitationSustaining Health After an Intensive Weight-loss Pro-gramme
- Where
- Copenhagen
- People
- 150
- Run by
- Copenhagen University Hospital, Hvidovre
See details and how to joinNCT07900178 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Esbjerg, Frederiksberg, Herlev, Herning, Hvidovre, Roskilde
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - No phaseTaking peopleChanges in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.
- Where
- Hellerup
- Age
- 20 years to 40 years
- People
- 20
- Run by
- University Hospital, Gentofte, Copenhagen
See details and how to joinNCT07893743 - Phase 3Not yet taking people in DenmarkA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Aabenraa, Aarhus N, Herlev, Herning, Hvidovre, Kolding
- Age
- 45 years to 64 years
- People
- 8,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00 - No phaseNot yet taking people in DenmarkDanish Trial of Weight Loss to Reduce Atrial Fibrillation Progression
- Where
- Copenhagen, Esbjerg
- Age
- 18 years and over
- People
- 480
- Run by
- Axel Brandes
See details and how to joinNCT07816744 - Phase 1Taking peopleA Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or Placebo
- Where
- Aarhus N
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07757087 · EU 2025-522744-40-00 - Phase 3Taking peopleA Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Where
- Holbæk
- Age
- 8 years to 18 years
- People
- 460 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00 - Phase 3Taking peopleAMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Where
- Gandrup, Hellerup, Hilleroed, Hvidovre, Vejle
- Age
- 18 years and over
- People
- 1,150 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07339423 · EU 2024-520440-42-00 - Phase 3Taking peopleAMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Herning, Koege
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571005 · EU 2024-520442-36-00 - Phase 1Taking peopleThe Role of the Amylin Analogue Cagrilintide in Bone Metabolism
- Where
- Herlev
- Age
- 50 years to 70 years
- People
- 144
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07010432 · EU 2024-517883-49-00 - Phase 3Taking peopleResearch Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Where
- Aarhus N, Hellerup, Herning
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07770841 · EU 2025-524626-18-00 - No phaseTaking peopleIntensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial
- Where
- Aarhus, Esbjerg, Hvidovre, Viborg
- Age
- 18 years to 60 years
- People
- 500 worldwide
- Run by
- Carsten Dirksen
See details and how to joinNCT06309238 - Phase 3Taking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Aabenraa, Copenhagen Oe, Frederiksberg, Herlev, Hjoerring, Holbæk, Hvidovre, Svendborg, Viborg
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - Phase 3Taking peopleAMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Where
- Aarhus N, Frederiksberg, Herlev
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07509307 · EU 2024-520445-23-00